SCHEMBL7480704

SCHEMBL7480704

CCOc1cc(-c2nnc3c4ccccc4c(Cl)nn23)on1

nearest known ligand 0.49

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
RXFP1 Q9HBX9 1/20 0.49
L3MBTL1 Q9Y468 1/20 0.49
LMNA P02545 1/20 0.41
GABRG2 P18507 12/20 0.40
GABRB3 P28472 12/20 0.40
GABRA5 P31644 12/20 0.40
GABRA3 P34903 12/20 0.40
GABRA2 P47869 12/20 0.40
GABRA1 P14867 11/20 0.40
GABRA4 P48169 1/20 0.40
GABRA6 Q16445 1/20 0.40
NPC1 O15118 1/20 0.37
TSHR P16473 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7486259 0.78 GABRA1 (0.49) GABRG2GABRB3GABRA5GABRA3GABRA2
SCHEMBL7478081 0.74 RXFP1 (0.52) RXFP1L3MBTL1LMNAGABRG2GABRB3
SCHEMBL31058084 0.72 GABRA1 (0.58) RXFP1L3MBTL1LMNAGABRG2GABRB3
SCHEMBL1258627 0.72 GABRA1 (0.58) RXFP1L3MBTL1LMNAGABRG2GABRB3
SCHEMBL21362800 0.72 GABRG2 (0.50) RXFP1L3MBTL1LMNAGABRG2GABRB3
SCHEMBL7451922 0.71 RXFP1 (0.58) RXFP1L3MBTL1LMNAGABRG2GABRB3
SCHEMBL7957849 0.71 LMNA (0.72) RXFP1L3MBTL1LMNAGABRG2GABRB3
SCHEMBL7479344 0.70 RXFP1 (0.57) RXFP1L3MBTL1LMNAGABRG2GABRB3
SCHEMBL7480128 0.70 RXFP1 (0.57) RXFP1L3MBTL1LMNAGABRG2GABRB3
SCHEMBL18973197 0.70 RXFP1 (0.57) RXFP1L3MBTL1LMNAGABRG2GABRB3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0986562-B1 SUBSTITUTED 1,2,4-TRIAZOLO 3,4-A]PHTHALAZINE DERIVATIVES AS GABA ALPHA 5 LIGANDS MERCK SHARP & DOHME (GB) 2002-08-07 EP disclosed
US-6200975-B1 FOR COGNITION ENHANCEMENT THERAPY MERCK SHARP & DOHME LIMITED (GB) 2001-03-13 US disclosed